A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Ensem Therapeutics
PMV Pharmaceuticals, Inc
Eli Lilly and Company
Theravectys S.A.
Perspective Therapeutics
Second Life Therapeutics
BicycleTx Limited
Shasqi, Inc.
Maastricht University Medical Center
LigaChem Biosciences, Inc.
Bolt Biotherapeutics, Inc.
Palleon Pharmaceuticals, Inc.
Sensei Biotherapeutics, Inc.
Incyte Corporation
Marengo Therapeutics, Inc.
ModeX Therapeutics, An OPKO Health Company
Cancer Research UK
UNICANCER
Cyteir Therapeutics, Inc.
Aminex Therapeutics, Inc.
NextCure, Inc.
Compugen Ltd
SCG Cell Therapy Pte. Ltd.
Second Affiliated Hospital of Guangzhou Medical University
Innolake Biopharm
GeneMedicine Co., Ltd.
University of Southampton
Dana-Farber Cancer Institute
CytomX Therapeutics
Klus Pharma Inc.
Kineta Inc.
Advaxis, Inc.
Incyte Corporation
Petra Pharma
Memorial Sloan Kettering Cancer Center
Centocor, Inc.
Memorial Sloan Kettering Cancer Center
Duke University